Results 231 to 240 of about 55,162 (292)

Clinical and genotypic characteristics of 19 children with STXBP1-encephalopathy. [PDF]

Medicine (Baltimore)
Qi L, Fang C, Hu Z.
europepmc   +1 more source

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study

British Journal of Clinical Pharmacology, EarlyView.
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga, Stefano Agliardi, Riccardo Giossi, Alice Schianchi, Alessandra Romandini, Thomas Virdis, Silvia Nerini Molteni, Maria Luisa De Angelis, Stefania Paccagnini, Cecilia Gechtman, Alice Proto, Marco Fossati, Silvia Oliveri, Giulia Angela Pattarino, Elena Altieri, Agnese Graziosi, Arianna Pani, Romano Danesi, Stefano Martinelli, Costantino De Giacomo, Francesco Scaglione   +20 more
wiley   +1 more source

Efficacy and safety of intravenous Levetiracetam as first-line treatment for neonatal clinical seizures: A single-center study (2021-2023). [PDF]

eNeurologicalSci
Movahedinia M, Mirjalili SR, Ardekani NA, Shamsi F.   +3 more
europepmc   +1 more source

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, Elvira Bramon, Helen Cross, Natalie Curley, Sarah Curran, Helen Davies, Jana De Villiers, William Evans, Bernhard Frank, Alice Groves, Judith Hayward, Jon Higham, Dyfrig A. Hughes, Shwe Sin Kyaw, Anthony G. Marson, Ailsa McLellan, Seth Mensah, Francis O'Neill, Jane Sargison, Sanjay M. Sisodiya, Jill Swan, Joanna M. Zakrewska, Munir Pirmohamed   +24 more
wiley   +1 more source

A novel hereditary encephalopathy in four related Labrador Retrievers associated with a missense variant in the ALDH5A1 gene. [PDF]

J Vet Intern Med
Schofield E, Butler T, Gonçalves R, Pettitt L, Wyatt S, Jenkins CA, De Frias JM, McLaughlin B, Pilkington E, Orlandi R, Mellersh CS, Freeman P, Prunty H, Ricketts SL, Harris G.   +14 more
europepmc   +1 more source

Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal.

JAMA Netw Open
Wolpaw BJ, Oren H, Quinnan-Hostein L, Bradley KA, Johnson NJ, Hallgren KA, Gupta A, Kim HN, Granich MA, Steel TL.   +9 more
europepmc   +1 more source

Treatment outcome and its predictors among patients with status epilepticus in Africa: A systematic review and meta-analysis. [PDF]

Explor Res Clin Soc Pharm
Geremew GW, Wassie YA, Zeleke TK, Abebe RB, Tadesse G, Fentahun S, Anberbr SS, Ayele HS, Mengesha AK, Getachew D, Beyna AT, Worku MC, Bekalu AF, Tekle MT, Alemayehu TT.   +14 more
europepmc   +1 more source

Optimizing phenobarbital dosing in critically ill patients with refractory and superrefractory status epilepticus using a population pharmacokinetic model. [PDF]

Epilepsia
Stoschus M, Schmidbauer ML, Starp J, Kunst S, Gakis G, Paal M, Vogeser M, Scharf-Janssen C, Liebchen U, Dimitriadis K.   +9 more
europepmc   +1 more source

Effects of Phenobarbital and Prednisolone on Neurological Signs of Canine Distemper. [PDF]

Vet Med Sci
Sarchahi AA, Arbabi M, Mohebalian H.
europepmc   +1 more source

<i>KCNQ2</i> Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients. [PDF]

Neurol Genet
Li Y, Li J, Li L, Zhang H, Sun X.
europepmc   +1 more source